Diabetes and hormone care in Singapore: what each door costs

Roughly one adult in ten in Singapore has diabetes, and the health system is built to keep most of them out of hospital endocrinology clinics. Polyclinics and enrolled GPs manage the disease; the hospital clinics take what the primary care tier cannot. This entry sets out that division, the ten providers that carry the specialist work, and what each level costs.

What decides the outcome

Whether you need a specialist at all. Type 2 diabetes with reasonable control, hypertension and high cholesterol are polyclinic and GP conditions under the Chronic Disease Management Programme, with MediSave and CHAS subsidies. A specialist referral is for insulin initiation that is not going well, complications, type 1 disease, pregnancy, or a thyroid, adrenal or pituitary problem.

The team around the clinic. Diabetes outcomes depend on foot screening, eye screening, kidney monitoring and diet counselling being done on schedule. The hospital diabetes centres bundle these; a bare specialist consultation does not.

Cost per year, not per visit. Chronic disease is priced by the year. The subsidised route with MediSave for medication is designed to keep that figure manageable; the private route is not.

Singapore General Hospital — Department of Endocrinology

SGH’s endocrinology department is the largest in the country and runs the SGH Diabetes Centre, which combines specialist clinics with diabetes education, dietetics, podiatry and retinal screening in one location. It is also the SingHealth referral centre for pituitary, adrenal and rare endocrine disease.

Tan Tock Seng Hospital — Department of Endocrinology

TTSH’s endocrinology service covers the central region with diabetes and thyroid clinics, an insulin pump programme and a diabetes foot service tied to vascular surgery. Complex thyroid cancer is managed with the hospital’s head and neck surgeons.

National University Hospital — Division of Endocrinology

NUH’s division runs the NUHS cluster’s diabetes and endocrine services with documented programmes in type 1 diabetes, diabetes in pregnancy with the women’s centre, and obesity medicine. Paediatric endocrinology, including childhood diabetes and growth disorders, runs through the children’s hospital.

Changi General Hospital, Khoo Teck Puat Hospital and Sengkang General Hospital

Each runs a diabetes centre with specialist clinics and allied health, and each is the subsidised referral destination for its region. KTPH’s diabetes service has a documented community programme linked to northern polyclinics.

KK Women’s and Children’s Hospital — Paediatric Endocrinology

KKH runs the national paediatric endocrine service: type 1 diabetes in children, growth and puberty disorders, congenital thyroid and adrenal conditions, and the neonatal screening follow-up. Referrals come from polyclinics, GPs and paediatricians nationwide.

Polyclinics and Healthier SG GPs

Not a hospital, but the tier that treats most patients. Polyclinics run diabetes clinics with nurse educators, annual foot and eye screening, and subsidised medication. An enrolled Healthier SG GP does the same with subsidised chronic medication and the same screening schedule. Both refer to the hospital clinics when control fails or complications appear.

Mount Elizabeth and Gleneagles — Endocrinology practices

Private endocrinologists at the Parkway hospitals see diabetes, thyroid and metabolic disease at private rates, with same-week appointments and in-house laboratory access. Choice is by doctor; several trained in the public departments above.

Raffles Diabetes & Endocrine Centre

Raffles Hospital’s in-house endocrine service with published fees, diabetes education and dietetics on site, and a same-system path from any Raffles GP clinic.

Public versus private, in practice

Chronic disease care is priced by where you are seen, and the published consultation fees show that ladder plainly.

Consultation	Citizen	Permanent resident	Non-resident
SingHealth polyclinic	S$18.50, or S$8.50 for a child or senior	S$37.50	S$85.35
NHG polyclinic, general	S$19.60, or S$9.00 for a child or senior	S$45.80	S$88.40
NHG polyclinic, family physician clinic	S$39.50	S$62.00	S$118.81
Hospital specialist, subsidised	S$34–84 first visit	S$90 at one institute	—
Hospital specialist, private	S$106–225 first visit	Same	Higher again

Three things in that table are not obvious.

The two polyclinic clusters do not charge the same. A citizen pays roughly a dollar more at an NHG polyclinic than a SingHealth one — trivial. But a permanent resident pays S$37.50 against S$45.80, a gap of over eight dollars for the same kind of visit. Nobody chooses a polyclinic by cluster, but it is worth knowing the price is not national.

The family physician clinic is a second tier, not a nicer room. At NHG it is S$39.50 for a citizen against S$19.60 at a general clinic — double. It exists for more complex chronic cases, which is exactly the population this entry is about, so it is the tier many diabetes patients actually sit in.

The step to a hospital specialist is smaller than people fear, if subsidised. A first specialist visit at S$34–84 against a polyclinic’s S$19.60 is not the cliff the word “specialist” suggests. The cliff is the referral: without one, the same visit is S$106–225.

Three rows were removed from this table rather than corrected: monthly costs for oral diabetes drugs, for newer GLP-1 and SGLT2 agents, and for insulin. No published source was found for any of them. Drug pricing varies by the specific agent, the dose and the subsidy tier a patient qualifies for, and a band covering all of that would mislead more than it helped. Ask the pharmacy for the actual monthly figure for your prescription.

Medication at subsidised clinics can be paid from MediSave under the Chronic Disease Management Programme up to an annual cap, with a cash co-payment. Newer drug classes are subsidised only against published clinical criteria. Verify current prices with the clinic; drug lists and subsidy tiers are revised.

What a referral actually looks like

Most patients are referred back rather than forward: the hospital clinic stabilises a difficult case and discharges it to the polyclinic or GP with a care plan. Referral to a specialist starts at the polyclinic or CHAS GP for the subsidised rate. Thyroid nodules go to endocrinology for assessment and to surgery or nuclear medicine for treatment; the endocrine clinic coordinates.

Frequently asked questions

Do I need to see a hospital specialist for type 2 diabetes?

Usually not. Polyclinics and enrolled GPs manage most type 2 diabetes with the same drugs and screening schedule. Specialist referral is for poor control despite treatment, complications, or insulin problems.

Which hospital is best for diabetes in Singapore?

For complex cases, SGH and NUH have the largest departments and the fullest diabetes centres. For routine specialist care, the nearest public hospital’s diabetes centre offers the same bundle.

Can MediSave pay for diabetes medication?

Yes, at clinics under the Chronic Disease Management Programme — polyclinics, CHAS GPs and public specialist clinics — up to an annual limit per account, with a cash co-payment on each bill.

Are newer diabetes drugs subsidised?

Some are, for patients who meet published criteria such as heart or kidney disease. Outside the criteria they are available at unsubsidised prices.

Check also

• Nephrology hospitals in Singapore — where diabetic kidney disease goes next
• Ophthalmology hospitals in Singapore — diabetic eye screening and treatment
• GP or specialist? The referral chain — why most diabetes care stays at primary care and what that saves

Where this index comes from

The consultation fees were read on 24 September 2026 from the two polyclinic clusters’ own charges pages, and the hospital specialist bands from Khoo Teck Puat Hospital and the National Neuroscience Institute, whose published schedules are used here as representative of a subsidised and a private first visit. Those figures are kept as data alongside the entry so a later check can say which have moved.

No figure here comes from a private provider’s price list any more. The drug rows that did were removed rather than adjusted, because nothing published supported them.

This round verified the fees only. The department descriptions, the Chronic Disease Management Programme rules and the drug subsidy criteria were not re-sourced, so the date applies to the numbers and not to the prose around them.